COMMUNIQUÉS West-GlobeNewswire

Infant Bacterial Therapeutics publishes prospectus in connection with the list change to Nasdaq Stockholm
04/09/2018
On August 30, 2018, Infant Bacterial Therapeutics AB (publ) (”IBT” or the ”Company”) announced that Nasdaq Stockholm’s Listing Committee had approved the admission of the Company’s shares of series B for trading on [...]
Announcement regarding the election of the Chairperson and deputy of the Council of JSC “Olainfarm”, as well as the changes in JSC “Olainfarm” Management Board
04/09/2018
JSC Olainfarm hereby informs about the following decisions taken by its Supervisory Council on September 4, 2018: Elect Pavels Rebenoks to be the Chairman of the Council of JSC “Olainfarm”; Elect Irina Maligina to be [...]
Collegium Announces Scientific Presentations at PAINWeek 2018 Meeting
04/09/2018
STOUGHTON, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it has supported the following poster presentations on tapentadol (Nucynta® and Nucynta® ER), at [...]
RESOLUTIONS of the Extraordinary General Meeting of Shareholders held on September 04th, 2018
04/09/2018
Amendment of Statutes . Decision: Reject draft decision published by JSC “Olainfarm” Management Board. Voting results: decision is taken with the required majority of votes. Supplementing Agenda with additional items. [...]
Key Biologics and Blood Centers of America Partner to Advance Cell Therapy and Regenerative Medicine
04/09/2018
Collaboration aims to open up access to important new therapies MEMPHIS, Tenn. and WEST WARWICK, R.I., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Key Biologics LLC and Blood Centers of America (BCA) today announced an agreement [...]
CORRECTING and REPLACING -- Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors
04/09/2018
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today by Ziopharm Oncology , Inc. (Nasdaq:ZIOP), please note the Company's upcoming annual meeting of stockholders is being held Sept. 18 rather [...]
Radius Health Appoints Dr. Charles Morris as Chief Medical Officer
04/09/2018
WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) today announced the appointment of Dr. Charles Morris as Chief Medical Officer. Dr. Morris will oversee [...]
Medtronic EVP & CFO Karen L. Parkhill to Speak at Morgan Stanley Global Healthcare Conference
04/09/2018
DUBLIN - September 4, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Friday, September 14 [...]
OrthoPediatrics Corp. to Participate at the Morgan Stanley 16th Annual Global Healthcare Conference
04/09/2018
WARSAW, Ind., Sept. 04, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & [...]
Grown Rogue Builds a Multi-State Seed-to-Experience Cannabis Brand -- CFN Media
04/09/2018
SEATTLE, WA, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Abeona Announces Participation at Upcoming Conferences
04/09/2018
Citi's 13th Annual Biotech Conference - September 5-6 th in Boston, MA Jefferies Gene Therapy Summit - September 27 th in New York, NY NEW YORK and CLEVELAND, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc [...]
Sarepta Therapeutics to Present at Two Upcoming Investor Conferences
04/09/2018
CAMBRIDGE, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
Cannabis Leaf is Now Apotheca Biosciences (PCFP), Company's Products and R & D Focuses on Opioid Crisis, a National Public Health Emergency
04/09/2018
SAINT PETERSBURG, FL, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
Scythian Biosciences Corp. Announces Andy DeFrancesco as a New Director
04/09/2018
TORONTO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today that it has appointed Andrew DeFrancesco to [...]
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2019 After Market Close on September 10, 2018
04/09/2018
TUSTIN, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
NeoChord Announces Successful Completion of First Beating Heart Repair Procedures in China
04/09/2018
ST. LOUIS PARK, Minn., Sept. 04, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve [...]
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients
04/09/2018
MIAMI, Sept. 04, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) has initiated a Phase 2 clinical trial to study the safety and efficacy of RAYALDEE ® as a new treatment for secondary hyperparathyroidism (SHPT [...]
Zogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut Syndrome
04/09/2018
67% of Patients Achieved At Least a 50% Reduction in Convulsive Seizures Global Phase 3 Randomized, Controlled Study in LGS Currently Enrolling Patients EMERYVILLE, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, [...]
MediWound to Present at 13th Annual Wells Fargo Securities Healthcare Conference
04/09/2018
YAVNE, Israel, Sept. 04, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]

Pages